Synergy among antibacterial peptides and between peptides and small-molecule antibiotics

Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo- -Lactamase-Producing Klebsiella pneumoniae Isolates?

(2009) M. Souli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Antibacterial Effect of a Proline-Rich Antibacterial Peptide A3-APO

(2009) F. Rozgonyi et al.   CURRENT MEDICINAL CHEMISTRY

Antibodies as Crypts of Antiinfective and Antitumor Peptides

(2009) W. Magliani et al.   CURRENT MEDICINAL CHEMISTRY

The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest® and time-kill assay

(2009) George A. Pankey et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models

(2009) Dora Szabo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Induced Resistance to the Designer Proline-rich Antimicrobial Peptide A3-APO does not Involve Changes in the Intracellular Target DnaK

(2009) Marco Cassone et al.   International Journal of Peptide Research and Therapeutics

Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

(2009) N. Aoki et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Potential of immunomodulatory host defense peptides as novel anti-infectives

(2009) Donna M. Easton et al.   TRENDS IN BIOTECHNOLOGY

Activity of Levofloxacin Alone and in Combination with a DnaK Inhibitor against Gram-Negative Rods, Including Levofloxacin-Resistant Strains

(2008) K. Credito et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Protective effects of the combination of α-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection

(2008) Oscar Cirioni et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics

(2008) Marco Cassone et al.   PEPTIDES

Antibody Complementarity-Determining Regions (CDRs) Can Display Differential Antimicrobial, Antiviral and Antitumor Activities

(2008) Luciano Polonelli et al.   PLoS One

Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo

(2008) Paul Bart Noto et al.   PROTEIN SCIENCE